skip to main content

Amiodarone long-term treatment — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

ModerateCardiovascular TherapeuticsAmiodarone long-term treatmentGPhC CRA

A 76-year-old man takes long-term amiodarone 200 mg daily for AF and asks why repeated blood tests and respiratory checks are arranged. What monitoring is required?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: C — Thyroid, liver, electrolytes and pulmonary toxicity monitoring

This scenario assesses Amiodarone long-term treatment in a UK pharmacy practice context. Amiodarone can cause thyroid dysfunction, hepatotoxicity, pulmonary toxicity and arrhythmia risk with electrolyte disturbance. The best answer is Thyroid, liver, electrolytes and pulmonary toxicity monitoring because it addresses the principal clinical, legal or safety issue before routine supply. The other options are less appropriate because they either miss the key risk, delay necessary review, or would not meet expected BNF, NICE, MEP, MHRA or GPhC practice standards.

Reference: BNF